Gene: NCALD

83988
-
neurocalcin delta
protein-coding
8q22.3
Ensembl:ENSG00000104490 MIM:606722 Vega:OTTHUMG00000164876 UniprotKB:P61601
NC_000008.11
SNP Mapped
ND|AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
3.739e-1 (AD)  7.591e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs2155235chr8:102055399 (GRCh38.p7)C>Tnicotine dependenceSNV(Single Nucleotide Variation)
rs12544026chr8:101819970 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
RGS40.975
RASGRF10.967
TMEM1550.964
SYT130.962
GABRA10.962
PRKCE0.96
GABBR20.958
KCNC20.957
SYT10.952
SV2B0.952

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
REST-0.592
WWTR1-0.591
RNF135-0.579
YES1-0.567
RAB13-0.567
ACAP1-0.567
ARHGEF5-0.563
CMTM3-0.56
HEY2-0.559
CHST14-0.559

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of NCALD mRNA"22698814|2890350
C0164032,4-dinitrotoluene"2,4-dinitrotoluene affects the expression of NCALD mRNA"21346803
C0235142,6-dinitrotoluene"2,6-dinitrotoluene results in decreased expression of NCALD mRNA"20406850
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of NCALD mRNA29067470
D000082AcetaminophenAcetaminophen affects the expression of NCALD mRNA17562736
D016604Aflatoxin B1Aflatoxin B1 affects the expression of NCALD protein20106945
D000393Air PollutantsAir Pollutants analog results in decreased expression of NCALD mRNA21757418
D018501Antirheumatic AgentsAntirheumatic Agents results in increased expression of NCALD mRNA24449571
D001104ArbutinArbutin results in decreased expression of NCALD mRNA17103032
D001194AsbestosAsbestos results in decreased expression of NCALD mRNA21563230
D001205Ascorbic AcidAscorbic Acid results in increased expression of NCALD mRNA15305145
D001280AtrazineAtrazine results in increased expression of NCALD mRNA22378314
C487081belinostatbelinostat results in decreased expression of NCALD mRNA26272509
C487081belinostat"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of NCALD mRNA21569818
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of NCALD mRNA22228805
D004958Estradiol[bisphenol A co-treated with Estradiol] results in decreased expression of NCALD mRNA26496021
C044887beta-methylcholinebeta-methylcholine affects the expression of NCALD mRNA21179406
C006780bisphenol Abisphenol A affects the expression of NCALD mRNA20170705
C006780bisphenol A[bisphenol A co-treated with Estradiol] results in decreased expression of NCALD mRNA26496021
C006780bisphenol Abisphenol A results in decreased expression of NCALD mRNA25181051
C037123cadmium sulfatecadmium sulfate affects the reaction [MTF1 affects the expression of NCALD mRNA]16221973
D020245p-Chloromercuribenzoic Acid"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
D020245p-Chloromercuribenzoic Acidp-Chloromercuribenzoic Acid results in decreased expression of NCALD mRNA26272509
D002737ChloropreneChloroprene results in decreased expression of NCALD mRNA23125180
D003042CocaineCocaine results in decreased expression of NCALD mRNA18355967
D003042CocaineFOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of NCALD mRNA]18355967
D003471CuprizoneCuprizone results in decreased expression of NCALD mRNA26577399
D016572CyclosporineCyclosporine results in decreased expression of NCALD mRNA20106945|2798913
D003561CytarabineCytarabine results in increased expression of NCALD mRNA21198554
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of NCALD mRNA21266533
D019422Dietary SucroseDietary Sucrose results in increased expression of NCALD mRNA26033743
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of NCALD mRNA19638242
D004054DiethylstilbestrolDiethylstilbestrol results in increased expression of NCALD mRNA17005392
D004237DiuronDiuron results in increased expression of NCALD mRNA21551480
C118739entinostatentinostat results in decreased expression of NCALD mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
D000431EthanolEthanol results in increased expression of NCALD mRNA19167417
D000431EthanolEthanol results in decreased expression of NCALD protein23702218
D004997Ethinyl Estradiol[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NCALD mRNA17942748
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of NCALD mRNA20170705
C024565ethylene dichlorideethylene dichloride results in increased expression of NCALD mRNA28189721
D005485FlutamideFlutamide results in decreased expression of NCALD mRNA24136188
D005839GentamicinsGentamicins results in decreased expression of NCALD mRNA22061828
D017313FenretinideFenretinide results in increased expression of NCALD mRNA28973697
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of NCALD mRNA26752646
C011890kojic acidkojic acid results in decreased expression of NCALD mRNA16595896
C042720mercuric bromidemercuric bromide results in decreased expression of NCALD mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
D008694MethamphetamineMethamphetamine affects the expression of NCALD protein17904249
C005219methyl cellosolvemethyl cellosolve results in increased expression of NCALD mRNA21061450
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of NCALD mRNA23179753|2627250
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of NCALD mRNA28001369
C004925methylmercuric chloride"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in decreased expression of NCALD mRNA23649840
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of NCALD mRNA"25620056
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of NCALD mRNA"25620056
D009532NickelNickel results in decreased expression of NCALD mRNA24768652|2558310
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C496932panobinostatpanobinostat results in decreased expression of NCALD mRNA26272509
C016030pantogabpantogab results in decreased expression of NCALD mRNA17379144
D010634PhenobarbitalNR1I3 protein affects the reaction [Phenobarbital results in increased expression of NCALD mRNA]19482888
D010634PhenobarbitalPhenobarbital affects the expression of NCALD mRNA23091169
D010634PhenobarbitalPhenobarbital results in increased expression of NCALD mRNA19482888
D010656PhenylephrinePhenylephrine results in increased expression of NCALD mRNA18158353
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in decreased expression of NCALD mRNA26272509
D010795Phthalic AcidsPhthalic Acids results in increased expression of NCALD mRNA21061450
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NCALD mRNA19710929
C006253pirinixic acid[pirinixic acid co-treated with PPARA] results in increased expression of NCALD mRNA20813756
C006253pirinixic acidpirinixic acid results in increased expression of NCALD mRNA17426115|2081375
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of NCALD mRNA25895662
D012999SomanSoman results in decreased expression of NCALD mRNA19281266
D053260SootSoot results in decreased expression of NCALD mRNA26551751
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of NCALD mRNA21570461|2468072
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NCALD mRNA17942748
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of NCALD mRNA21215274
D019284ThapsigarginThapsigargin results in decreased expression of NCALD mRNA22378314
C009495titanium dioxidetitanium dioxide results in increased expression of NCALD mRNA23557971
D014212TretinoinTretinoin results in decreased expression of NCALD mRNA21934132
D014212TretinoinTretinoin results in decreased expression of NCALD mRNA20488242
D014241TrichloroethyleneTrichloroethylene results in increased methylation of NCALD gene27618143
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
C012589trichostatin Atrichostatin A results in decreased expression of NCALD mRNA24935251|2627250
C012589trichostatin Atrichostatin A results in decreased expression of NCALD mRNA15901671
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of NCALD mRNA"26179874
D014415TunicamycinTunicamycin results in decreased expression of NCALD mRNA22378314
C406224valdecoxibvaldecoxib results in increased expression of NCALD mRNA24136188
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of NCALD mRNA25979313
D014635Valproic AcidValproic Acid results in decreased expression of NCALD mRNA23179753|2627250
D014635Valproic AcidValproic Acid results in increased expression of NCALD mRNA23179753|2800136
D014635Valproic AcidValproic Acid affects the expression of NCALD mRNA17292431
D014635Valproic AcidValproic Acid results in decreased expression of NCALD mRNA15901671
D001335Vehicle EmissionsVehicle Emissions affects the methylation of NCALD gene25560391
C025643vinclozolinvinclozolin affects the expression of NCALD mRNA19015723
C111237vorinostatvorinostat results in decreased expression of NCALD mRNA26272509

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0003779actin binding-IDA11964161  
GO:0005509calcium ion binding-IEA-  
GO:0005515protein binding-IPI16189514  21516116  25416956  25519916  
GO:0015276ligand-gated ion channel activity-TAS-  
GO:0015631tubulin binding-IDA11964161  
GO:0030276clathrin binding-IDA11964161  
GO:0043014alpha-tubulin binding-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0003073regulation of systemic arterial blood pressure-IEA-  
GO:0016192vesicle-mediated transport-NAS11964161  
GO:0019722calcium-mediated signaling-IEA-  
GO:0034220ion transmembrane transport-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005622intracellular-IDA-  
GO:0005829cytosol-NAS11964161  
GO:0005829cytosol-TAS-  
GO:0030130clathrin coat of trans-Golgi network vesicle-NAS11964161  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-112314Neurotransmitter receptors and postsynaptic signal transmissionTAS
R-HSA-112315Transmission across Chemical SynapsesTAS
R-HSA-112316Neuronal SystemTAS
R-HSA-451306Ionotropic activity of kainate receptorsTAS
R-HSA-451308Activation of Ca-permeable Kainate ReceptorTAS
R-HSA-451326Activation of kainate receptors upon glutamate bindingTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal